Advertisement · 728 × 90
#
Hashtag
#TranslationalBytes
Advertisement · 728 × 90
Post image

#CTSjournal authors Wenjie Wang and Da Xu discuss one of the pivotal findings of their recent study in the latest #TranslationalBytes post: bit.ly/4sSclqX

0 1 0 0
Post image

#CTSjournal Editor-in-Chief John Wagner gives a year end review for 2025 in the latest #TranslationalBytes: bit.ly/3OmO2SQ

0 0 0 0
Preview
Guiding Drug Developers in Therapeutic Peptide Projects: Insights to Drug-Drug Interaction Risks from Recent Approvals Are you involved in drug development for therapeutic peptides—whether in DMPK, clinical pharmacology, or other related disciplines? Are you unsure of how the development program differs from your stan

Are you involved in drug development for therapeutic peptides—whether in DMPK, clinical pharmacology, or other related disciplines? In the latest #TranslationalBytes learn about a recent industry position paper to guide colleagues in this area. bit.ly/4ramChZ

0 0 0 0
Post image

The 2025 #CTSjournal award highlights the most outstanding CTS paper written by a student or trainee - learn more about this year's recipient in the latest #TranslationalBytes blog post: bit.ly/432VcAq

1 0 0 0
Preview
Are We Missing the Risk? Rethinking Restraint-Based Cardiovascular Monitoring in Nonclinical Toxicology Studies Identifying cardiovascular (CV) risks early in drug development is essential, especially for detecting arrhythmias and hemodynamic changes. Despite this, many nonclinical toxicology studies still rely

#CTSjournal authors Kim A. Henderson, Nicholas Ether, and Hugo M. Vargas discuss risks in nonclinical toxicology studies in the most recent #TranslationalBytes post: bit.ly/3IpbVXx

0 0 0 0
Preview
“Large” Time for a Primer: Larger Impacts with Large Language Models Large language models (LLMs), like ChatGPT, are no longer just tech-world curiosities; they’re increasingly making their way into drug discovery and clinical development. In this new Clinical and Tran

#CTSjournal author, James Lu discusses the role LLMs can have in the future of clinical pharmacology and translational science in the latest #TranslationalBytes: bit.ly/3IawfvA

0 0 0 0
This graphic previews the title of the "Translational Byes" post: "Enhancing Eligibility Assessment with Personal Health Records in a Fully Remote Trial" by Yoonjin Kim, MD
The text is accompanied by a figure from the blog post ad the cover image of CTS

This graphic previews the title of the "Translational Byes" post: "Enhancing Eligibility Assessment with Personal Health Records in a Fully Remote Trial" by Yoonjin Kim, MD The text is accompanied by a figure from the blog post ad the cover image of CTS

Check out the latest post from #TranslationalBytes! #CTSjournal author Yoonjin Kim discusses data integrity and personal health records in decentralized trials! bit.ly/4fFJHEa

0 0 0 0
This image provides a preview of four of the pieces published in the May 2025 issue of Clinical and Translational Science (Volume 18, Issue 5).  This preview shows the titles of two tutorials and two brief reviews.

This image provides a preview of four of the pieces published in the May 2025 issue of Clinical and Translational Science (Volume 18, Issue 5). This preview shows the titles of two tutorials and two brief reviews.

#CTSAuthor Lyn Frumkin explains her recent tutorial discussing resource-limited investigator-sponsored studies in the latest #TranslationalBytes Post. #TranslationalTuesday bit.ly/447cYlM

0 0 0 0
CTS Journal Preview
Exploration of Using an Open-Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements
Includes a figure from the article.

CTS Journal Preview Exploration of Using an Open-Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements Includes a figure from the article.

📑 #CTSjournal RESEARCH SPOTLIGHT: "Exploration of Using an Open-Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements", check the full research article referenced in the latest #TranslationalBytes.
bit.ly/4d83sCI

1 0 0 0
Check out this blog post from "Translational Bytes" by Clinical and Translational Science
Common Language for Cancer Detection Technology!
Dorys Lopez, PhD, Christina A. Clarke, PhD, MPH, and Breeana L. Mitchell, PhD
https://bit.ly/3RcNMEe

Check out this blog post from "Translational Bytes" by Clinical and Translational Science Common Language for Cancer Detection Technology! Dorys Lopez, PhD, Christina A. Clarke, PhD, MPH, and Breeana L. Mitchell, PhD https://bit.ly/3RcNMEe

In the rapidly evolving field of single-cancer detection and multi-cancer detection testing technology, ensuring that all stakeholders use consistent language becomes critical to overcoming communication challenges. Find out more in the latest #TranslationalBytes @bloodpac.bsky.social

2 0 0 1
Translational Bytes Post Preview:
What if you Could Experiment on Your Electronic Self
by Iraj Hosseini, PhD

Translational Bytes Post Preview: What if you Could Experiment on Your Electronic Self by Iraj Hosseini, PhD

What is a digital twin? Learn more about this powerful concept for personalized medicine in the latest #TranslationalBytes post from #CTSjournal: bit.ly/41sYTz2

1 0 0 0
CTS: Ringing in 2025, and Looking Back on a Strong 2024
-Translational Bytes Post

CTS: Ringing in 2025, and Looking Back on a Strong 2024 -Translational Bytes Post

2024 was a great year fro #CTSjournal - read the year in review from Editor in Chief John Wagner in the latest #TranslationalBytes post. bit.ly/40rZzCR

0 0 0 0
Post image

#CTSjournal author Pamela Davis discusses Electronic Health Record Big Data in the latest post from #TranslationalBytes: bit.ly/4a9MZg0

1 0 0 0
Post image

Author Ryo Nakamura provides more insight on his #CTSjournal study in the latest blog post from #TranslationalBytes: bit.ly/3VOjMB8

1 0 0 0